libri scuola books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro

kuhn wilfried (curatore); kraus peter (curatore); przuntek horst (curatore) - deprenyl — past and future

Deprenyl — Past and Future

; ;




Disponibilità: Normalmente disponibile in 15 giorni


PREZZO
54,98 €
NICEPRICE
52,23 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

Springer

Pubblicazione: 12/1996
Edizione: Softcover reprint of the original 1st ed. 1996





Trama

Expert clinicians and basic scientists with a special interest in Parkinson's disease review the current state of science and clinical therapeutics of the disease. Therefore these articles represent an authorative review of the current state of knowledge regarding preclinical course and symptomatology, subtypes with their impact on the pathology, genetic alterations, novel mechanisms of neuronal cell death, diagnostic tools and old and novel therapeutic approaches with respect to neuroprotection and neuroregeneration in Parkinson's disease. Particular emphasis has been placed on a novel antiparkinsonian drug called budipine with various modes of action also influencing altered non dopaminergic systems in Parkinson's disease. It is evident, that many questions on the cause, course and treatment of Parkinson's disease are still unanswered and therefore the ideal way to treat a parkinsonian patient remains to be defined.




Sommario

New aspects of pathology in Parkinson’s disease with concomitant incipient Alzheimer’s disease.- New horizons in molecular mechanisms underlying Parkinson’s disease and in our understanding of the neuroprotective effects of selegiline.- Early diagnosis in Parkinson’s disease — limitation of biochemical markers and instrumental methods.- The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (−)-deprenyl research.- (−)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.- Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical research.- Deprenyl in the treatment of Parkinson’s disease: clinical effects and speculations on mechanism of action.- 8The clinical potential of Deprenyl in neurologic and psychiatric disorders.- Pharmacology and neuroprotective properties of rasagiline.- Potential of neurotrophic factors in therapy of Parkinson’s disease.










Altre Informazioni

ISBN:

9783211828915

Condizione: Nuovo
Collana: Journal of Neural Transmission. Supplementa
Dimensioni: 280 x 210 mm
Formato: Brossura
Illustration Notes:IX, 117 p.
Pagine Arabe: 117
Pagine Romane: ix


Dicono di noi